Immune evasion of SARS-CoV-2 variants of concern is driven by low affinity to neutralizing antibodies

Matheus V F Ferraz1, Emerson G Moreira, Danilo F Coêlho

  • 1Aggeu Magalhães Institute, Oswaldo Cruz Foundation, Recife, PE, Brazil. roberto.lins@cpqam.fiocruz.br.

Chemical Communications (Cambridge, England)
|May 26, 2021
PubMed